Q32 Bio Inc. (QTTB) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
QTTB currently has 17M outstanding shares. with significant dilution risk as 147M authorized shares could dilute existing holders by 869.0%. The company has significantly diluted shareholders by 37.72% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 05, 2026 |
10-Q filing | 17.0M shares outstanding |
17M | 150M |
| Mar 10, 2026 |
10-K filing | 14.6M shares outstanding |
15M | 150M |
| Nov 13, 2025 |
10-Q filing | 12.2M shares outstanding |
12M | 150M |
| Aug 06, 2025 |
10-Q filing | 12.2M shares outstanding |
12M | 150M |
| May 08, 2025 |
10-Q filing | 12.2M shares outstanding |
12M | 150M |
| Apr 11, 2025 |
S-3 filing: The company may offer up to $200,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants, and units in one or more offerings. |
12M | 150M |
| Apr 11, 2025 |
POS AM filing: This prospectus relates to the proposed offer and resale of up to 1,682,045 shares of common stock by the selling stockholders. |
12M | 150M |
| Mar 11, 2025 |
10-K filing | 12.2M shares outstanding |
12M | 35M |
| Nov 07, 2024 |
10-Q filing | 12.1M shares outstanding |
12M | 35M |
| Aug 08, 2024 |
10-Q filing | 12.0M shares outstanding |
12M | 35M |
| May 09, 2024 |
10-Q filing | 11.9M shares outstanding |
12M | 35M |
| Apr 19, 2024 |
S-1 filing: Registration of resale of common stock by selling stockholders. |
58M | 0 |
| Mar 13, 2024 |
10-K filing | 57.8M shares outstanding |
58M | 0 |
| Nov 14, 2023 |
10-Q filing | 57.9M shares outstanding |
58M | 0 |
| Aug 14, 2023 |
10-Q filing | 57.8M shares outstanding |
58M | 0 |
| May 11, 2023 |
10-Q filing | 57.7M shares outstanding |
58M | 0 |
| Mar 09, 2023 |
S-3 filing: The company may offer and sell up to $250,000,000 in common stock, preferred stock, and debt securities from time to time. |
57M | 0 |
| Mar 09, 2023 |
10-K filing | 57.4M shares outstanding |
57M | 0 |
| Nov 10, 2022 |
10-Q filing | 57.4M shares outstanding |
57M | 0 |
| Aug 15, 2022 |
10-Q filing | 57.4M shares outstanding |
57M | 0 |
| May 16, 2022 |
10-Q filing | 57.3M shares outstanding |
57M | 0 |
| Mar 23, 2022 |
10-K filing | 57.4M shares outstanding |
57M | 0 |
| Nov 15, 2021 |
10-Q filing | 57.2M shares outstanding |
57M | 0 |
| Aug 12, 2021 |
10-Q filing | 57.1M shares outstanding |
57M | 0 |
| May 06, 2021 |
10-Q filing | 57.1M shares outstanding |
57M | 0 |
| Mar 11, 2021 |
10-K filing | 50.5M shares outstanding |
50M | 0 |
| Mar 11, 2021 |
POS AM filing: The company has an agreement to sell shares of its common stock from time to time through Cowen, acting as its agent, for an aggregate offering price of up to $148,391,990. |
45M | 0 |
| Nov 09, 2020 |
10-Q filing | 45.3M shares outstanding |
45M | 0 |
| Aug 10, 2020 |
10-Q filing | 45.2M shares outstanding |
45M | 0 |
| May 07, 2020 |
10-Q filing | 45.2M shares outstanding |
45M | 0 |
| Mar 12, 2020 |
10-K filing | 45.2M shares outstanding |
45M | 0 |